Warnings over major cancer target overhaul

By Sharon Brennan2018-09-25T06:31:00

A major change to the measurement of cancer performance will produce misleading results and perverse incentives for some providers, several trust leaders have told HSJ.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here